27799314|t|IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7 / 8 Agonist R848 (Resiquimod)
27799314|a|Different models of experimental allergic asthma have shown that the TLR7 / 8 agonist resiquimod (R848) is a potential inhibitor of type 2 helper cell -driven inflammatory responses. However, the mechanisms mediating its therapeutic effects are not fully understood. Using a model of experimental allergic asthma, we show that induction of IL-27 by R848 is critical for the observed ameliorative effects. R848 significantly inhibited all hallmarks of experimental allergic asthma, including airway hyperreactivity, eosinophilic airway inflammation, mucus hypersecretion, and Ag - specific Ig production. Whereas R848 significantly reduced IL-5, IL-13, and IL-17, it induced IFN-γ and IL-27. Neutralization of IL-27 completely reversed the therapeutic effect of R848 in the experimental asthma model, demonstrating dependence of R848 -mediated suppression on IL-27. In vitro, R848 induced production of IL-27 by murine alveolar macrophages and dendritic cells and enhanced expression of programmed death-ligand 1, whose expression on monocytes and dendritic cells has been shown to regulate peripheral tolerance in both murine and human studies. Moreover, in vitro IL-27 enhanced secretion of IFN-γ whereas it inhibited IL-5 and IL-13, demonstrating its direct effect on attenuating Th2 responses. Taken together, our study proves that R848 -mediated suppression of experimental asthma is dependent on IL-27. These data provide evidence of a central role of IL-27 for the control of Th2 -mediated allergic diseases.
27799314	0	5	IL-27	T103	UMLS:C1706289
27799314	23	34	Suppression	T058	UMLS:C0021079
27799314	51	66	Allergic Asthma	T038	UMLS:C0155877
27799314	74	78	TLR7	T103	UMLS:C1579758
27799314	81	82	8	T103	UMLS:C1579755
27799314	83	90	Agonist	T103	UMLS:C2987634
27799314	91	95	R848	T103	UMLS:C3642356
27799314	97	107	Resiquimod	T103	UMLS:C0965594
27799314	119	141	models of experimental	T038	UMLS:C0684309
27799314	142	157	allergic asthma	T038	UMLS:C0155877
27799314	178	182	TLR7	T103	UMLS:C1579758
27799314	185	186	8	T103	UMLS:C1579755
27799314	187	194	agonist	T103	UMLS:C2987634
27799314	195	205	resiquimod	T103	UMLS:C0965594
27799314	207	211	R848	T103	UMLS:C3642356
27799314	241	259	type 2 helper cell	T017	UMLS:C0242633
27799314	268	290	inflammatory responses	T038	UMLS:C1155266
27799314	330	349	therapeutic effects	T201	UMLS:C1527144
27799314	384	405	model of experimental	T038	UMLS:C0684309
27799314	406	421	allergic asthma	T038	UMLS:C0155877
27799314	436	445	induction	T058	UMLS:C0857127
27799314	449	454	IL-27	T103	UMLS:C1706289
27799314	458	462	R848	T103	UMLS:C3642356
27799314	514	518	R848	T103	UMLS:C3642356
27799314	547	556	hallmarks	T017	UMLS:C1512330
27799314	573	588	allergic asthma	T038	UMLS:C0155877
27799314	600	622	airway hyperreactivity	T038	UMLS:C0004096
27799314	637	643	airway	T017	UMLS:C0458827
27799314	644	656	inflammation	T038	UMLS:C0021368
27799314	658	678	mucus hypersecretion	T038	UMLS:C0155872
27799314	684	686	Ag	T103	UMLS:C0003320
27799314	689	700	specific Ig	T103	UMLS:C0358334
27799314	701	711	production	T038	UMLS:C0003261
27799314	721	725	R848	T103	UMLS:C3642356
27799314	748	752	IL-5	T103	UMLS:C0021759
27799314	754	759	IL-13	T103	UMLS:C0214743
27799314	765	770	IL-17	T103	UMLS:C0384648
27799314	783	788	IFN-γ	T103	UMLS:C3539881
27799314	793	798	IL-27	T103	UMLS:C1706289
27799314	818	823	IL-27	T103	UMLS:C1706289
27799314	848	866	therapeutic effect	T201	UMLS:C1527144
27799314	870	874	R848	T103	UMLS:C3642356
27799314	895	901	asthma	T038	UMLS:C0004096
27799314	902	907	model	T038	UMLS:C0684309
27799314	937	941	R848	T103	UMLS:C3642356
27799314	952	963	suppression	T058	UMLS:C0021079
27799314	967	972	IL-27	T103	UMLS:C1706289
27799314	984	988	R848	T103	UMLS:C3642356
27799314	989	996	induced	T058	UMLS:C0857127
27799314	1011	1016	IL-27	T103	UMLS:C1706289
27799314	1020	1026	murine	T204	UMLS:C0026809
27799314	1027	1047	alveolar macrophages	T017	UMLS:C0085236
27799314	1052	1067	dendritic cells	T017	UMLS:C0011306
27799314	1081	1091	expression	T038	UMLS:C1171362
27799314	1128	1138	expression	T038	UMLS:C1171362
27799314	1142	1151	monocytes	T017	UMLS:C0085236
27799314	1156	1171	dendritic cells	T017	UMLS:C0011306
27799314	1190	1198	regulate	T038	UMLS:C1327622
27799314	1199	1219	peripheral tolerance	T038	UMLS:C3179073
27799314	1228	1234	murine	T204	UMLS:C0026809
27799314	1239	1244	human	T204	UMLS:C0086418
27799314	1273	1278	IL-27	T103	UMLS:C1706289
27799314	1288	1297	secretion	T038	UMLS:C1327616
27799314	1301	1306	IFN-γ	T103	UMLS:C3539881
27799314	1328	1332	IL-5	T103	UMLS:C0021759
27799314	1337	1342	IL-13	T103	UMLS:C0214743
27799314	1391	1394	Th2	T017	UMLS:C0242633
27799314	1444	1448	R848	T103	UMLS:C3642356
27799314	1459	1470	suppression	T058	UMLS:C0021079
27799314	1487	1493	asthma	T038	UMLS:C0004096
27799314	1510	1515	IL-27	T103	UMLS:C1706289
27799314	1566	1571	IL-27	T103	UMLS:C1706289
27799314	1591	1594	Th2	T017	UMLS:C0242633
27799314	1605	1622	allergic diseases	T038	UMLS:C1504369